fda warning bpc-157 peptide unapproved drug panel narrowly backs touted by Joe Rogan FDA Issues Warning: Compounding Certain

In summary, the reasons a GP surgery may refuse an early B12 injection are often rooted in a strict interpretation of established, but imperfect, guidelines, a misunderstanding of the actual science of B12 storage and metabolism, and a desire to maintain administrative consistency

Want to stay ahead

Simponi (golimumab) for ulcerative colitis Golimumab (brand name Simponi) is an injectable biologic medication licensed to treat adults with moderate to severe ulcerative colitis

Specifically, the relatively small sample size, the unbalanced male/female ratio (with a higher number of males in two of the three cohorts), and the short intervention period constrained our ability to assess the long-term effects of the Sucrosomial B12 formulation